1. Home
  2. IT vs BMRN Comparison

IT vs BMRN Comparison

Compare IT & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$164.27

Market Cap

9.8B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$56.68

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
BMRN
Founded
1979
1996
Country
United States
United States
Employees
40
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
10.4B
IPO Year
2010
1999

Fundamental Metrics

Financial Performance
Metric
IT
BMRN
Price
$164.27
$56.68
Analyst Decision
Hold
Buy
Analyst Count
9
18
Target Price
$189.25
$88.22
AVG Volume (30 Days)
1.5M
2.1M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.18
0.54
Revenue
$2,021,441,000.00
$1,313,646,000.00
Revenue This Year
$3.52
$15.02
Revenue Next Year
$5.08
$12.23
P/E Ratio
$50.60
$97.67
Revenue Growth
13.30
17.62
52 Week Low
$139.18
$49.26
52 Week High
$434.12
$66.28

Technical Indicators

Market Signals
Indicator
IT
BMRN
Relative Strength Index (RSI) 61.15 61.54
Support Level $142.37 $51.74
Resistance Level $172.23 $56.91
Average True Range (ATR) 7.01 1.72
MACD 1.50 0.44
Stochastic Oscillator 92.92 98.01

Price Performance

Historical Comparison
IT
BMRN

About IT Gartner Inc.

Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: